Advertisements

Alergical Cream

Quick links to important sections

Alergical Cream

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Alergical Cream

Quick Facts

Property Description
Active ingredients Betamethasone, Fluocinolone
Form Cream (Topical)
Pharmacological Class Corticosteroid (Glucocorticoid)
Common Use Managing skin inflammation and allergic reactions
Origin Synthetic

What Type of Medicine is Alergical Cream?

Alergical Cream is a prescription-only pharmaceutical preparation developed for topical application and is classified within the corticosteroid group of medicines. It is recognized as a fixed-dose combination product because its formulation contains two distinct active synthetic agents: Betamethasone and Fluocinolone. Glucocorticoids, the specific type of corticosteroids utilized in this medicine, are recognized for their potent anti-inflammatory and immunosuppressive properties. This dual-agent structure is a key differentiator, often reserved for dermatological conditions that require a robust therapeutic response.

Composition: A Combination of Potent Glucocorticoids

The medicine's efficacy is driven by the combination of two established synthetic halogenated corticosteroids: Betamethasone and Fluocinolone. This structure distinguishes it from most single-active-ingredient preparations. The agents are delivered in a cream base, a semisolid emulsion suitable for the cutaneous route of administration. This cream vehicle is a practical choice, as its non-occlusive nature and ease of application provide advantages over heavier oil-based ointments when treating large or acute inflammatory areas.

How Its Action Provides General Symptom Relief

The general purpose of Alergical Cream is to achieve powerful and rapid relief from the disruptive, visible symptoms associated with various inflammatory and allergic skin disorders. The dual-agent corticosteroid action is designed to produce a potent response by suppressing the production of chemical mediators that signal inflammation in the skin. This fundamental action effectively targets the root cause of the distress, leading directly to the abatement of key symptoms, notably tissue swelling, pronounced erythema (redness), and intense pruritus (itching).

Regulatory References

  1. Glucocorticoids - StatPearls - NCBI Bookshelf - NIH
Advertisements

What side effects are possible with Alergical Cream?

Possible Side Effects and Safety Information

The safety profile for Alergical Cream, a potent combination topical corticosteroid, is defined by potential local reactions at the application site and the risk of systemic effects due to drug absorption.

Local Adverse Reactions

The majority of documented side effects involve the Skin and Subcutaneous Tissue Disorders class. These reactions are often classified in regulatory documents as infrequent or reported in less than 1% of clinical trial patients. Common examples include burning, itching, irritation, and dryness at the application site. Other documented effects are folliculitis, acneiform eruptions, hypopigmentation, and skin atrophy (thinning). Certain local reactions, such as striae (stretch marks) and significant atrophy, may be noted as potentially irreversible .

Systemic Safety Considerations

Regulatory agencies highlight the risk of systemic absorption, especially with prolonged exposure to excessively large doses. This can lead to serious adverse reactions classified under Endocrine System Disorders. These include reversible Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and the development of Cushing's syndrome manifestations. Ophthalmic disorders such as glaucoma and cataracts are also documented as potential systemic consequences.

Population-Specific Safety Notes

The official label contains specific safety notes for certain populations. Pediatric patients are noted as having greater susceptibility to systemic toxicity (HPA axis suppression) due to their higher skin surface area to body weight ratio, requiring specific attention to their growth and development. Use during pregnancy is advised only if the potential benefit justifies the potential risk to the fetus, reflecting the classification of corticosteroids as teratogenic in animal studies.

Safety-Related Restrictions

Use is formally contraindicated in individuals with a history of hypersensitivity to any component of the preparation. Additionally, official labeling advises against use in the presence of certain local skin infections (e.g., viral, fungal) and conditions such as rosacea or perioral dermatitis.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Presentations

Overdose of Alergical Cream may result from excessive or prolonged use, leading to the systemic absorption of its topical corticosteroid component. The documented serious manifestations of overdose involve the endocrine system and include reversible hypothalamic-pituitary-adrenal (HPA) axis suppression and the development of Cushing's syndrome.

Physiological effects of systemic absorption can include hyperglycemia (high blood sugar) and glucosuria (sugar in the urine).

Populations at Higher Risk

Pediatric patients are identified as being at a greater risk for systemic toxicity, including HPA axis suppression and Cushing's syndrome, due to their higher ratio of skin surface area to body mass. This increased risk also extends to potential glucocorticosteroid insufficiency following the withdrawal of treatment.

Required Emergency Actions

If you suspect an overdose, such as by applying too much of this medicine or using it for a prolonged period beyond prescribed limits, you must contact a poison control center or emergency room at once.

Management of overdose typically involves adjusting the dose or discontinuing the cream entirely, followed by the initiation of symptomatic and supportive treatment. Tests such as the ACTH stimulation test may be necessary to evaluate the degree of HPA axis suppression.

Advertisements

Therapeutic Uses of Alergical Cream

What Alergical Cream Treats: Main Uses and Benefits

Therapeutic Support for Inflammatory Conditions

The cream is relevant to situations requiring symptomatic support across conditions involving inflammatory or irritative processes. This class of medicine is commonly used to help with symptoms associated with conditions like eczema, psoriasis, and various types of dermatitis.

Managing Acute and Disruptive Symptoms

The medication is often used during phases when symptoms intensify and supportive relief is needed, and is applied in addressing symptom clusters that may become intense or disruptive. This is relevant for easing pruritus (itching), helping with pronounced redness (erythema), and supporting management of tissue swelling. Applied across domains where additional symptomatic support is needed, the cream assists with maintaining a sense of stability when symptoms are more noticeable during acute episodes of these conditions.


Quick Fact: Relief for Inflammatory Symptoms

The medicine supports patients during difficult episodes by easing distress associated with visible inflammation and intense skin discomfort.

Regulatory References

  1. NIH MedlinePlus overview of Betamethasone Topical
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Alergical Cream?

Eligibility for Alergical Cream, a potent fixed-dose combination of Betamethasone and Fluocinolone, is strictly defined by regulatory authorities to minimize systemic absorption and local risk. This medicine is available by prescription only.


Absolute Contraindications

Alergical Cream must not be used by patients with:

  • A known hypersensitivity to Betamethasone, Fluocinolone, other corticosteroids, or any component of the cream.
  • Untreated primary skin infections caused by bacteria, fungi, viruses (e.g., herpes simplex), or parasites.
  • Specific facial dermatoses, including Rosacea, Acne Vulgaris, or Perioral dermatitis.
  • Pre-existing skin atrophy at the intended site of application.

Conditional Use and Restrictions

Use is restricted in several populations due to increased risk of systemic side effects:

Population Regulatory Restriction
Pediatric Patients Use is generally not recommended for infants and younger children due to a higher risk of systemic toxicity (e.g., HPA axis suppression).
Pregnancy/Lactation Use is conditional; allowed only if the clinical benefit justifies the potential risk. Should not be applied to the breast while breastfeeding.
High-Risk Sites Use is restricted or contraindicated on the face, groin, axillae, or eyelids.
Comorbidities Caution is required for patients with diabetes mellitus due to the glucocorticoid's potential to affect blood glucose levels.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Alergical Cream is based on the risk of systemic absorption of its potent corticosteroid components, Betamethasone and Fluocinolone, as documented in regulatory sources.


Documented Pharmacodynamic Interactions

Systemic absorption of the corticosteroid can lead to pharmacodynamic antagonism of medicinal products used to control blood sugar. Co-administration with antidiabetic agents, such as insulin or oral hypoglycemics, may reduce their effectiveness by raising blood glucose levels.

Exposure-Modifying Interactions and Restrictions

The simultaneous use of Alergical Cream with other corticosteroid medications (topical or systemic) is associated with an increased risk of systemic exposure and accumulation. Official regulatory information also notes that the use of occlusive dressings or application over a large surface area will augment the percutaneous absorption of the active ingredients.

Population-Specific Interaction Notes

Specific populations are noted to have altered interaction risk due to higher systemic exposure: pediatric patients (infants and small children) have a greater surface area-to-mass ratio, increasing absorption risk. Additionally, patients with hepatic impairment may have reduced clearance of the absorbed components, and those with pre-existing Diabetes Mellitus require monitoring due to the potential for blood sugar elevation.

Advertisements

Mechanism of Action

The anti-inflammatory effects of Alergical Cream are driven by the combined action of the two synthetic glucocorticoids, Betamethasone and Fluocinolone, which engage mechanisms that modulate specific signaling pathways at the cellular level.

Direct Gene Modulation via Glucocorticoid Receptor Agonism

The active ingredients bind to and activate the intracellular Glucocorticoid Receptor (GR) with high affinity. The activated complex translocates to the cell nucleus to modulate gene transcription, primarily through transrepression of pro-inflammatory factors like NF-kappaB. This mechanism initiates the cascade that modulates the gene expression of inflammatory mediators and immune cell components.

Suppression of the Arachidonic Acid Cascade

A critical consequence of this genomic action is the enhanced synthesis of the protein Annexin A1. Annexin A1 then acts as an indirect inhibitor of the enzyme Phospholipase A2 (PLA2). By blocking PLA2, the drug modifies an early molecular step, preventing the release of Arachidonic Acid and subsequently halting the synthesis of pro-inflammatory eicosanoids, such as prostaglandins and leukotrienes.

Local Microvascular Regulation and Physiological Dampening

The combination exerts its effect on local tissue dynamics through vasoconstriction in the superficial blood vessels. This, along with the deep suppression of mediator release and immune cell activity, physically limits capillary permeability and fluid accumulation in the affected area. This mechanism contributes to the dampening of signaling associated with heightened immune responses.

Advertisements

Dosage and Administration Information

How to Use Alergical Cream

The principles governing the use of Alergical Cream—a combination product containing the potent corticosteroids Betamethasone and Fluocinolone—follow standard administration guidelines for high-potency topical glucocorticoids. The medicine is strictly for topical, dermatologic use only and is not approved for application via any other route.

Application Regimen and Administration Constraints

The cream is typically applied as a thin film to the affected skin areas once daily or twice daily, as prescribed by the clinician. The total quantity of Alergical Cream applied to the body should be limited, consistent with the maximum allowance of 50 grams per week for potent corticosteroid preparations. The standard protocol mandates that the cream be gently rubbed in until it disappears and that the user wash hands after application.

Duration of Treatment and Restrictions

Therapy with this potent combination is generally intended for short-term use, and the treatment should be discontinued when control is achieved, rather than being used for extended periods. For high-potency agents, it is advised against continuous use beyond two consecutive weeks to manage the risk of systemic absorption. Crucially, the medicine must not be applied to the face, groin, or axillae (armpits) due to the increased rate of absorption in these areas. Furthermore, occlusive dressings, such as bandages or tight clothing, should never be used over the treated area unless specifically directed, as this significantly increases the absorption of the active ingredients.

Pediatric Use Rule

Caution is emphasized when considering use in pediatric patients. Administration should be limited to the least amount and shortest duration compatible with an effective regimen, and use in children under 13 years of age is generally not recommended.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Alergical Cream

The clinical research base for Alergical Cream focuses on the active ingredients, Betamethasone and Fluocinolone, and how they were evaluated in research exploring how symptoms change over defined time intervals in conditions characterized by fluctuating or episodic manifestations like dermatitis and psoriasis. This research was studied for the purpose of exploring how symptoms change over defined time intervals.


Evidence for Use in Eczema and Atopic Dermatitis

The research landscape for the active components in evaluating symptom patterns associated with eczema and atopic dermatitis relies primarily on short-term Randomized Controlled Trials (RCTs) and supporting Systematic Reviews and Meta-analyses. Research examined the short-term patterns of change in the physical symptoms of the conditions.

Researchers in these trials focused on outcomes related to physical discomfort and changes in the skin's condition, which were usually assessed by physicians using Global Assessment scales. Studies reported how symptoms evolved in the observed populations, and research highlighted changes measured during the study period in areas like skin redness and thickening. Some trials described patterns observed in how these signs were documented when compared to an inactive base (placebo) or other treatments.


Evidence in Specific Patient Populations

The active agents in Alergical Cream were evaluated in a range of populations, including both adults and children. Studies also explored patient-reported experiences across different disease severity groups, typically focusing on individuals with moderate or severe inflammatory conditions.

For these specific populations, the trials monitored outcomes related to systemic or functional imbalance and reported how symptoms evolved in these groups. Study results reflect the specific conditions under which they were conducted. The results apply only to the populations studied, and data for certain specific subgroups, such as pregnant populations or those with particular comorbidities, remain insufficient.


Gaps in Research and Areas of Uncertainty

A primary gap is that research has explored short-term symptom changes, but data on long-term outcomes are not fully established. Additionally, while the medication is a combination of two agents, comparative evidence is lacking for the comparison of outcomes between the dual-agent product and a single potent active agent alone. Overall, the evidence quality varies across studies, and findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Psoriasis: assessment and management (NICE Guideline CG153)
  2. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities (2019)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Alergical Cream (FAQ)


Q: How quickly does Alergical Cream start to work?

Official product information describes that the cream is formulated to provide powerful and rapid relief from inflammatory symptoms. The active ingredients are designed to quickly begin modifying the inflammation signaling pathways within the skin shortly after application.

Q: Why do some people say Alergical Cream makes them feel itchy at first?

Itching and a burning feeling are listed in official documents as common local adverse reactions that have been reported at the application site. For some users, this sensation may be noticed in the moments immediately following the application of the cream. This is documented as one of the local skin reactions that has been reported.

Q: What's the difference between Alergical Cream and other creams for itching?

Regulatory descriptions state that Alergical Cream is categorized as a potent, fixed-dose combination product containing two synthetic corticosteroids. This classification distinguishes it from non-steroid or single-agent anti-itch creams, and it is officially categorized by its anti-inflammatory properties.

Q: Are there any specific foods or drinks I should avoid while using Alergical Cream?

The official regulatory documents on interactions focus on medicines that could pose a risk due to systemic absorption. They do not describe any specific foods or drinks that must be avoided while using this topical medicine.

Q: Can Alergical Cream be bought over-the-counter?

Alergical Cream is categorized as a prescription-only pharmaceutical preparation, meaning it requires an authorized prescription from a healthcare provider to be obtained. It is not available for purchase over-the-counter.

Q: How long can I continue to use Alergical Cream?

Official labels advise that therapy with this potent product is generally intended for short-term use. Furthermore, official labels advise against continuous use beyond two consecutive weeks to manage potential absorption risks.

Q: What happens if I forget a dose of Alergical Cream?

Regulatory patient information offers guidance for missed doses, which usually involves either applying the dose upon remembering or skipping it if the next scheduled dose is approaching. Specific guidance is found on the product label for the prescribed regimen.

Q: Can I apply makeup or other moisturizers after using Alergical Cream?

Official patient information generally cautions against applying other products, such as cosmetics or other topical skin care products, to the treated area unless use has been specifically directed by a healthcare professional.

Q: What should I do if I accidentally swallow a small amount of Alergical Cream?

Official documents describe that the amount of active ingredient in a typical quantity of cream is very low, and accidental oral ingestion is not expected to result in significant toxicity. Standard guidance suggests that contact with a poison control center or healthcare provider is typically initiated when this occurs.

Q: Can Alergical Cream be used with medicated shampoos?

The official label does not specifically mention medicated shampoos, but it cautions against the concurrent use of other corticosteroid-containing products. Applying any other substances to the treated area is generally advised to be done only with medical guidance.

Q: Does using more Alergical Cream make it work faster?

The use of quantities greater than the prescribed amount is associated with an increased risk of systemic absorption and side effects. This use is not noted in regulatory documents as increasing the speed or benefit of the product.

Q: What happens when I stop using Alergical Cream?

Official regulatory warnings mention that upon discontinuation, systemic effects, such as a temporary change in the HPA axis, are generally described as promptly reversible. As the anti-inflammatory action ends, the original skin condition symptoms may gradually return.

Q: Is Alergical Cream only for short-term use?

Yes, official labeling describes therapy with this potent combination as generally intended for short-term use. Use is recommended to be stopped once control of the symptoms is achieved, rather than being used for extended periods.

Q: Will Alergical Cream affect the results of a skin test?

As the product is a potent anti-inflammatory and immunosuppressive agent, its mechanism of action could potentially modify the body's normal inflammatory response. For this reason, use may interfere with the typical results of certain diagnostic skin tests.

Q: What is the consistency of Alergical Cream—is it greasy?

Official descriptions classify the product as a cream base, which is a type of semisolid emulsion. Creams are generally recognized for their non-occlusive nature and are considered less heavy or greasy compared to oil-based ointment formulations.

Q: Is there any research on Alergical Cream's effect on sleep due to reduced itching?

Clinical trials primarily evaluate the effects on core physical symptoms like pruritus (itching) and skin inflammation. A reduction in these key symptoms may indirectly be associated with improved patient-reported functional outcomes, but sleep is not listed as a primary, directly studied outcome in the official drug labels.

Q: Can Alergical Cream be used on broken skin?

Official product labeling generally advises that the cream should not be applied to open wounds, severely injured, or broken skin. This is due to the potential for increased systemic absorption of the active ingredients and the risk of developing side effects.

Q: Is Alergical Cream different from a generic 'anti-itch' cream?

Yes, Alergical Cream is categorized as a potent corticosteroid and is a prescription medicine. It is classified differently than non-prescription, generic anti-itch products, which often use non-steroidal ingredients.

Q: Are there any formal warnings about driving or operating machinery while using Alergical Cream?

Official regulatory documents typically state that, based on the known adverse effects profile from topical application, no detrimental effect on the ability to drive or operate machinery is expected or anticipated.

Advertisements

How should Alergical Cream be stored and disposed of?

How to Store and Dispose of Alergical Cream

The storage profile for Alergical Cream (topical corticosteroid) is strictly defined by regulatory documents to ensure product stability and public safety.

Official Storage Requirements

The cream must be stored at Controlled Room Temperature, typically between 15 C and 30 C (59 F and 86 F). It is mandatory to keep the product from freezing and store it away from excessive heat, moisture, and direct light. The container must be kept tightly closed when not in use. For safety, the medicine must be stored out of the reach of children.

Disposal Instructions

Unused or expired cream must not be disposed of in household waste, drains, or wastewater systems. Disposal must be performed in accordance with local, regional, and national regulations. Patients should utilize community drug take-back programs or consult a pharmacist for official disposal procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Alergical Cream found in:

A-Z Index: